$PRCT
PROCEPT BioRobotics Corp Stock $prct

$prct Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000158897823000028 Filed on November 02, 2023

Income Statement

Concept	2023 Q4	2023 Q3
Revenue	$43.58M	$35.10M
YoY Change	83.29%	72.5%
Cost Of Revenue	$22.33M	$16.23M
YoY Change	70.41%	60.39%
Gross Profit	$21.26M	$18.87M
YoY Change	99.09%	84.48%
Gross Profit Margin	48.77%	53.77%
Selling, General & Admin	$36.32M	$32.88M
YoY Change	39.49%	32.84%
% of Gross Profit	170.86%	174.22%
Research & Development	$14.50M	$11.60M
YoY Change	49.72%	52.99%
% of Gross Profit	68.2%	61.46%
Depreciation & Amortization	$1.318M	$1.049M
YoY Change	98.79%	49.22%
% of Gross Profit	6.2%	5.56%
Operating Expenses	$50.81M	$44.48M
YoY Change	42.27%	37.56%
Operating Profit	-$29.56M	-$25.61M
YoY Change	18.04%	15.85%
Interest Expense	$2.053M	$1.019M
YoY Change	1529.37%	-29.97%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$27.50M	-$24.62M
YoY Change	-2.37%	8.88%
Income Tax
% Of Pretax Income
Net Earnings	-$27.50M	-$24.62M
YoY Change	-2.37%	8.88%
Net Earnings / Revenue	-63.11%	-70.14%
Basic Earnings Per Share		-$0.51
Diluted Earnings Per Share	-$0.54	-$0.51
COMMON SHARES
Basic Shares Outstanding	50.50M shares	45.28M shares
Diluted Shares Outstanding		48.31M shares

Balance Sheet

Concept	2023 Q4	2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$257.2M	$287.1M
YoY Change	15.94%	15.2%
Cash & Equivalents	$257.2M	$287.1M
Short-Term Investments
Other Short-Term Assets	$5.213M	$4.758M
YoY Change	-25.01%	5.29%
Inventory	$39.76M	$42.20M
Prepaid Expenses
Receivables	$48.38M	$34.62M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$350.6M	$368.7M
YoY Change	28.59%	27.6%
LONG-TERM ASSETS
Property, Plant & Equipment	$28.75M	$27.03M
YoY Change	232.12%	427.97%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$919.0K	$415.0K
YoY Change	1701.96%	105.45%
Total Long-Term Assets	$54.15M	$52.46M
YoY Change	47.54%	49.43%
TOTAL ASSETS
Total Short-Term Assets	$350.6M	$368.7M
Total Long-Term Assets	$54.15M	$52.46M
Total Assets	$404.7M	$421.1M
YoY Change	30.84%	29.96%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$13.50M	$13.60M
YoY Change	43.74%	114.77%
Accrued Expenses	$18.57M	$14.97M
YoY Change	-10.22%	17.32%
Deferred Revenue	$5.656M	$5.007M
YoY Change	98.11%	113.79%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due		$0.00
YoY Change
Total Short-Term Liabilities	$45.93M	$41.36M
YoY Change	30.14%	51.16%
LONG-TERM LIABILITIES
Long-Term Debt	$51.34M	$51.31M
YoY Change	0.25%	1.21%
Other Long-Term Liabilities	$517.0K	$29.11M
YoY Change		14453.0%
Total Long-Term Liabilities	$51.86M	$51.31M
YoY Change	1.26%	0.82%
TOTAL LIABILITIES
Total Short-Term Liabilities	$45.93M	$41.36M
Total Long-Term Liabilities	$51.86M	$51.31M
Total Liabilities	$124.0M	$121.8M
YoY Change	10.43%	17.91%
SHAREHOLDERS EQUITY
Retained Earnings	-$454.6M	-$427.1M
YoY Change	30.37%	33.25%
Common Stock	$0.00	$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$280.8M	$299.4M
YoY Change
Total Liabilities & Shareholders Equity	$404.7M	$421.1M
YoY Change	30.84%	29.96%

Cashflow Statement

Concept	2023 Q4	2023 Q3
OPERATING ACTIVITIES
Net Income	-$27.50M	-$24.62M
YoY Change	-2.37%	8.88%
Depreciation, Depletion And Amortization	$1.318M	$1.049M
YoY Change	98.79%	49.22%
Cash From Operating Activities	-$24.79M	-$18.94M
YoY Change	-1.51%	-4.59%
INVESTING ACTIVITIES
Capital Expenditures	$8.715M	$5.781M
YoY Change	906.35%	-481.84%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$8.715M	-$5.781M
YoY Change	906.35%	281.84%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	2.866M	162.1M
YoY Change	-317.45%	20764.74%
NET CHANGE
Cash From Operating Activities	-24.79M	-18.94M
Cash From Investing Activities	-8.715M	-5.781M
Cash From Financing Activities	2.866M	162.1M
Net Change In Cash	-30.64M	137.4M
YoY Change	12.0%	-767.37%
FREE CASH FLOW
Cash From Operating Activities	-$24.79M	-$18.94M
Capital Expenditures	$8.715M	$5.781M
Free Cash Flow	-$33.51M	-$24.72M
YoY Change	28.68%	34.81%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q3	us-gaap	Restricted Cash Current RestrictedCashCurrent	777000	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	777000	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	34622000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	15272000	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	42201000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	28543000	usd
CY2023Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3981000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	6175000	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	368668000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	272626000	usd
CY2023Q3	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	3038000	usd
CY2022Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	3038000	usd
CY2022Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	1477000	usd
CY2023Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	415000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	51000	usd
CY2023Q3	us-gaap	Assets Assets	421125000	usd
CY2022Q4	us-gaap	Assets Assets	309329000	usd
CY2023Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	13597000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	9391000	usd
CY2023Q3	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	13265000	usd
CY2022Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	13447000	usd
CY2023Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	5007000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2855000	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1702000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2129000	usd
CY2023Q3	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	1859000	usd
CY2022Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	1779000	usd
CY2023Q3	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	517000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	0	usd
CY2023Q3	us-gaap	Liabilities Liabilities	121769000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	112257000	usd
CY2023Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	44828000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	44828000	shares
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	0	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	0	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	545753000	usd
CY2023Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-6000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-6000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	92610000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	51237000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	42816000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	24828000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	33950000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	19299000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	95457000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	62794000	usd
	us-gaap	Operating Expenses OperatingExpenses	129407000	usd
	us-gaap	Operating Expenses OperatingExpenses	82093000	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	1019000	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	1455000	usd
	us-gaap	Interest Expense InterestExpense	2870000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-78393000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-58982000	usd
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.33
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.33
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	44276000	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	197072000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	380000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Other Longterm Incentive Plans Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition	4137000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	21000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-28484000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	173126000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2430000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Other Longterm Incentive Plans Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition	5652000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-21000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-25285000	usd
CY2023Q3	us-gaap	Derivative Liability Statement Of Financial Position Extensible Enumeration DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2023#DerivativeLiabilitiesNoncurrent
CY2022Q4	us-gaap	Derivative Liability Statement Of Financial Position Extensible Enumeration DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2023#DerivativeLiabilitiesNoncurrent
CY2023Q3	us-gaap	Fair Value Recurring Basis Unobservable Input Reconciliation Net Derivative Asset Liability Gain Loss Statement Of Income Extensible List FairValueRecurringBasisUnobservableInputReconciliationNetDerivativeAssetLiabilityGainLossStatementOfIncomeExtensibleList	http://fasb.org/us-gaap/2023#IncreaseDecreaseInDerivativeLiabilities
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	27032000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8656000	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	20699000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	23481000	usd
CY2023Q3	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	1273000	usd
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	726428000	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-427066000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-348675000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	299356000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	197072000	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	421125000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	309329000	usd
	us-gaap	Gross Profit GrossProfit	49794000	usd
	us-gaap	Gross Profit GrossProfit	26409000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-79613000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-55684000	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	10795000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	161705000	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Other Longterm Incentive Plans Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition	5957000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-24622000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	267091000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1291000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Other Longterm Incentive Plans Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition	1552000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	1000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-17185000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2861000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Other Longterm Incentive Plans Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition	2676000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	85000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-19184000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	239188000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	777000	usd
CY2022Q3	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	185000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	19349000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	8375000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	12937000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	9502000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-2194000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	365000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	202000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-87000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	4243000	usd
	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	-182000	usd
	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	3810000	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	93000	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	688000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	2668000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	1318000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	4989000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	0	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	319000	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	1321000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-83210000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-55208000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	16491000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1787000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-16491000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1787000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	161705000	usd
	us-gaap	Proceeds From Repayment Of Loans By Employee Stock Ownership Plans ProceedsFromRepaymentOfLoansByEmployeeStockOwnershipPlans	1717000	usd
	us-gaap	Proceeds From Repayment Of Loans By Employee Stock Ownership Plans ProceedsFromRepaymentOfLoansByEmployeeStockOwnershipPlans	1289000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	164929000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4930000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	65228000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-52065000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	225674000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	305096000	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	287087000	usd
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	249217000	usd
CY2023Q3	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	3815000	usd
CY2022Q3	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	3814000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	290902000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	253031000	usd
	us-gaap	Interest Paid Net InterestPaidNet	3052000	usd
	us-gaap	Interest Paid Net InterestPaidNet	3573000	usd
	prct	Transfer From Inventory To Property And Equipment Net TransferFromInventoryToPropertyAndEquipmentNet	-123000	usd
	prct	Transfer From Inventory To Property And Equipment Net TransferFromInventoryToPropertyAndEquipmentNet	203000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	7837000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	200000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	22668000	usd
CY2023Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	16610000	usd
CY2023Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	1259000	usd
CY2023Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	24332000	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	42201000	usd
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	130000000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	185300000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	8900000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	27900000	usd
CY2023Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	12400000	usd
CY2023Q3	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	33.92
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	106800000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	126300000	usd
CY2023Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5326000	usd
CY2022Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3225000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	14153000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	7452000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-24622000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-22613000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-78393000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-58982000	usd
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	48310000	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	48310000	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	44640000	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	44640000	shares
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.51
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.51
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.51
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.51
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.33
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.33
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7109000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6114000	shares
	us-gaap	Operating Lease Expense OperatingLeaseExpense	6600000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	3300000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	35102000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	20349000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	92610000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	51237000	usd
CY2021Q4	prct	Lessee Operating Lease Number Of Renewal Options LesseeOperatingLeaseNumberOfRenewalOptions	2	renewaloption
CY2021Q4	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P5Y
CY2023Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	2600000	usd
CY2022Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	1900000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	1262000	usd
CY2023Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	0	usd
CY2023Q3	prct	Operating Lease Liability And Long Term Debt Maturity Remainder Of Fiscal Year OperatingLeaseLiabilityAndLongTermDebtMaturityRemainderOfFiscalYear	1262000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	4183000	usd
CY2023Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	0	usd
CY2023Q3	prct	Operating Lease Liability And Long Term Debt Maturity Year One OperatingLeaseLiabilityAndLongTermDebtMaturityYearOne	4183000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	4297000	usd
CY2023Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	4333000	usd
CY2023Q3	prct	Operating Lease Liability And Long Term Debt Maturity Year Two OperatingLeaseLiabilityAndLongTermDebtMaturityYearTwo	8630000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	4426000	usd
CY2023Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	26000000	usd
CY2023Q3	prct	Operating Lease Liability And Long Term Debt Maturity Year Three OperatingLeaseLiabilityAndLongTermDebtMaturityYearThree	30426000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	4808000	usd
CY2023Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	21667000	usd
CY2023Q3	prct	Operating Lease Liability And Long Term Debt Maturity Year Four OperatingLeaseLiabilityAndLongTermDebtMaturityYearFour	26475000	usd
CY2023Q3	prct	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	27250000	usd
CY2023Q3	prct	Long Term Debt Maturity After Year Four LongTermDebtMaturityAfterYearFour	0	usd
CY2023Q3	prct	Operating Lease Liability And Long Term Debt Maturity After Year Four OperatingLeaseLiabilityAndLongTermDebtMaturityAfterYearFour	27250000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	46226000	usd
CY2023Q3	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	52000000	usd
CY2023Q3	prct	Operating Lease Liability And Long Term Debt Maturity Gross OperatingLeaseLiabilityAndLongTermDebtMaturityGross	98226000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	17794000	usd
CY2023Q3	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	693000	usd
CY2023Q3	prct	Operating Lease Liability And Long Term Debt Maturity Unamortized Debt Discount OperatingLeaseLiabilityAndLongTermDebtMaturityUnamortizedDebtDiscount	18487000	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	28432000	usd
CY2023Q3	us-gaap	Long Term Debt LongTermDebt	51307000	usd
CY2023Q3	prct	Operating Lease Liability And Long Term Debt OperatingLeaseLiabilityAndLongTermDebt	79739000	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1702000	usd
CY2023Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	0	usd
CY2023Q3	prct	Operating Lease Liability And Long Term Debt Current OperatingLeaseLiabilityAndLongTermDebtCurrent	1702000	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	26730000	usd
CY2023Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	51307000	usd
CY2023Q3	prct	Operating Lease Liability And Long Term Debt Excluding Current Maturities OperatingLeaseLiabilityAndLongTermDebtExcludingCurrentMaturities	78037000	usd
CY2023Q3	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	400000	usd
CY2022Q3	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	0	usd
	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	1200000	usd
	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	0	usd
	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
CY2023Q3	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q3	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q3	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q3	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
prct-20230930_cal.xml	Edgar Link	unprocessable
0001588978-23-000028-index-headers.html	Edgar Link	pending
0001588978-23-000028-index.html	Edgar Link	pending
0001588978-23-000028.txt	Edgar Link	pending
0001588978-23-000028-xbrl.zip	Edgar Link	pending
amendedandrestated2021es.htm	Edgar Link	pending
amendedandrestated2021es001.jpg	Edgar Link	pending
amendedandrestated2021es002.jpg	Edgar Link	pending
amendedandrestated2021es003.jpg	Edgar Link	pending
amendedandrestated2021es004.jpg	Edgar Link	pending
amendedandrestated2021es005.jpg	Edgar Link	pending
amendedandrestated2021es006.jpg	Edgar Link	pending
amendedandrestated2021es007.jpg	Edgar Link	pending
amendedandrestated2021es008.jpg	Edgar Link	pending
amendedandrestated2021es009.jpg	Edgar Link	pending
amendedandrestated2021es010.jpg	Edgar Link	pending
amendedandrestated2021es011.jpg	Edgar Link	pending
amendedandrestated2021es012.jpg	Edgar Link	pending
amendedandrestated2021es013.jpg	Edgar Link	pending
amendedandrestated2021es014.jpg	Edgar Link	pending
amendedandrestated2021es015.jpg	Edgar Link	pending
amendedandrestated2021es016.jpg	Edgar Link	pending
amendedandrestated2021es017.jpg	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
prct-20230930.htm	Edgar Link	pending
prct-20230930.xsd	Edgar Link	pending
prct-ex311soxcertification.htm	Edgar Link	pending
prct-ex312soxcertification.htm	Edgar Link	pending
prct-ex321soxcertification.htm	Edgar Link	pending
prct-ex322soxcertification.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
prct-20230930_def.xml	Edgar Link	unprocessable
prct-20230930_lab.xml	Edgar Link	unprocessable
prct-20230930_pre.xml	Edgar Link	unprocessable
prct-20230930_htm.xml	Edgar Link	completed
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PRCT
PROCEPT BioRobotics Corp Stock $prct

2023 Q4 Form 10-Q Financial Statement

#000158897823000028 Filed on November 02, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PRCT PROCEPT BioRobotics Corp Stock $prct

2023 Q4 Form 10-Q Financial Statement

#000158897823000028 Filed on November 02, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PRCT
PROCEPT BioRobotics Corp Stock $prct